Loughborough University
Leicestershire, UK
LE11 3TU
+44 (0)1509 263171
Loughborough University

Loughborough University Institutional Repository

Please use this identifier to cite or link to this item: https://dspace.lboro.ac.uk/2134/23594

Title: Subclinical thyroid dysfunction and the risk of cognitive decline: a meta-analysis of prospective cohort studies
Authors: Rieben, Carole
Segna, Daniel
da Costa, Bruno R.
Collet, Tinh-Hai
Chaker, Layal
Aubert, Carole E.
Baumgartner, Christine
Almeida, Osvaldo P.
Hogervorst, Eef
Trompet, Stella
Masaki, Kamal
Mooijaart, Simon P.
Gussekloo, Jacobijn
Peeters, Robin P.
Bauer, Douglas C.
Aujesky, Drahomir
Rodondi, Nicolas
Issue Date: 2016
Publisher: © the Endocrine Society
Citation: RIEBEN, C. ... et al., 2016. Subclinical thyroid dysfunction and the risk of cognitive decline: a meta-analysis of prospective cohort studies. The Journal of Clinical Endocrinology & Metabolism, 101 (12), pp. jc.2016-2129 - jc.2016-2129.
Abstract: Context: Although both overt hyper- and hypothyroidism are known to lead to cognitive impairment, data on the association between subclinical thyroid dysfunction and cognitive function are conflicting. Objective: This study sought to determine the risk of dementia and cognitive decline associated with subclinical thyroid dysfunction among prospective cohorts. Data Sources: We searched in MEDLINE and EMBASE from inception until November 2014. Study Selection: Two physicians identified prospective cohorts that assessed thyroid function and cognitive outcomes (dementia; Mini-Mental State Examination [MMSE]). Data Extraction: Data were extracted by one reviewer following standardized protocols and verified by a second reviewer. The primary outcome was dementia and decline in cognitive function was the secondary outcome. Data Synthesis: Eleven prospective cohorts followed 16,805 participants during a median followup of 44.4 months. Five studies analyzed the risk of dementia in subclinical hyperthyroidism (SHyper) (n 6410), six in subclinical hypothyroidism (SHypo) (n 7401). Five studies analyzedMMSE decline in SHyper (n 7895), seven in SHypo (n 8960). In random-effects models, the pooled adjusted risk ratio for dementia in SHyper was 1.67 (95% confidence interval, 1.04; 2.69) and 1.14 (95% confidence interval, 0.84; 1.55) in SHypo vs euthyroidism, both without evidence of significant heterogeneity (I2 0.0%). The pooled mean MMSE decline from baseline to followup (mean 32 mo) did not significantly differ between SHyper or SHypo vs euthyroidism. Conclusions: SHyper might be associated with an elevated risk for dementia, whereas SHypo is not, and both conditions are not associated with faster decline in MMSE over time. Available data are limited, and additional large, high-quality studies are needed. (J Clin Endocrinol Metab 101: 4945– 4954, 2016) The
Description: This article was published in the Journal of Clinical Endocrinology and Metabolism [© Endocrine Society] and the definitive version is available at: http://dx.doi.org/10.1210/jc.2016-2129#sthash.DJcwERmE.dpuf
Sponsor: N.R.’s work is supported by a grant from the Swiss National Science Foundation (SNSF 320030-150025). T.-H.C.’s research is supported by grants from the Swiss National Science Foundation (PBLAP3-145870, P3SMP3-155318).
Version: Accepted for publication
DOI: 10.1210/jc.2016-2129
URI: https://dspace.lboro.ac.uk/2134/23594
Publisher Link: http://dx.doi.org/10.1210/jc.2016-2129
ISSN: 0021-972X
Appears in Collections:Published Articles (Sport, Exercise and Health Sciences)

Files associated with this item:

File Description SizeFormat
Revised Manuscript Thyroid and Cognition 2016 07 05_DS_CA.pdfAccepted version676.59 kBAdobe PDFView/Open

 

SFX Query

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.